awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34631149-9F73C7A0-50C3-4356-91B4-5A85939F4C0C
Q34631149-9F73C7A0-50C3-4356-91B4-5A85939F4C0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34631149-9F73C7A0-50C3-4356-91B4-5A85939F4C0C
Protease Inhibitors for Patients With HIV-1 Infection: A Comparative Overview.
P2860
Q34631149-9F73C7A0-50C3-4356-91B4-5A85939F4C0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34631149-9F73C7A0-50C3-4356-91B4-5A85939F4C0C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
84be18b658cea886246de6acf1e3761a062eb1af
P2860
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.